Rexahn Pharmaceuticals Submits Serdaxin(R) Phase II Protocol to FDA for Parkinson's Disease Apr 5, 2010
Rexahn Pharmaceuticals Announces Formation of Parkinson's Disease Scientific Advisory Board Mar 22, 2010